Q2 2018 Holdings
Filed 2018-08-06 | 8 holdings | $217.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Avrobio Inc | COM | 05455M100 | $78.1K | 2,736,027 | 35.9% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | COM | 24344T101 | $67.5K | 1,716,303 | 31.0% |
| Transenterix Inc | COM NEW | 89366M201 | $32.9K | 7,546,692 | 15.1% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $20.9K | 2,579,490 | 9.6% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $8.4K | 1,245,270 | 3.9% |
| Arsanis Inc | COM | 042873109 | $6.8K | 1,868,961 | 3.1% |
| Catabasis Pharmaceuticals in | COM | 14875P107 | $2.7K | 2,857,667 | 1.3% |
| Reshape Life Sciences Inc | COM | 29365M505 | $346 | 150,064 | 0.2% |